Showing results (71-80 of 610) with videos related to
Sort By:
Pageof 61
Thrombosis and Haemostasis|April 8, 1991
Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasmaP J Declerck, H R Lijnen, M Verstreken, et al.The Journal of Biological Chemistry|April 25, 1987
Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158L Nelles, H R Lijnen, D Collen, et al.The Journal of Biological Chemistry|February 5, 1987
Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin)W E Holmes, L Nelles, H R Lijnen, et al.Blood|April 16, 1998
Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in miceH R Lijnen, J Silence, B Van Hoef, et al.Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1)H R Lijnen, B Van Hoef, K Umans, et al.The Journal of Biological Chemistry|April 25, 1988
Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, W E Holmes, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injuryH R Lijnen, B Van Hoef, M Dewerchin, et al.European Journal of Biochemistry|September 15, 1994
Characterization of the murine plasma fibrinolytic systemH R Lijnen, B van Hoef, V Beelen, et al.Circulation|June 1, 1991
Small animal thrombosis models for the evaluation of thrombolytic agentsJ M Stassen, H R Lijnen, L Kieckens, et al.Thrombosis Research|February 1, 1990
Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activatorH R Lijnen, M Dewerchin, F De Cock, et al.Pageof 61